Transforming growth factor-β2-mediated regulation of C3 gene expression in monocytes

Molecular Immunology

Volumn 33, Issue 13, 1996, Pages 1025-1034

  Drouin, Scott M ^a   Carlino, Joseph A ^b   Barnum, Scott R ^a  

^a University of Alabama at Birmingham   (United States)

^b Celtrix Pharmaceuticals   (United States)

Author keywords

Complement; Monocytes; Transforming growth factor

Indexed keywords

COMPLEMENT COMPONENT C3; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; ARTICLE; CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

CELL LINE; COMPLEMENT C3; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; KINETICS; MONOCYTES; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 18844466804     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(96)00071-5     Document Type: Article

References (46)

1. Barnum S. R. (1993) Biosynthesis and regulation of complement by cells of the central nervous system. In Complement Today: Complement Profile (Edited by Cruse J. M. and Lewis R. E.), p. 76. Karger, Basel.
2. Barnum S. R., Fey G. and Tack B. F. (1989) Biosynthesis and genetics of C3. Curr. Topics Microbiol. Immun. 153, 23-43.
3. Barnum S. R. and Jones J. L. (1994) Transforming growth factor-β1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes. J. Immun. 152, 756-773.
4. Barnum S. R., Jones J. L. and Benveniste E. N. (1992) Interferon-gamma regulation of C3 gene expression in human astroglioma cells. J. Neuroimmun. 38, 275-282.
5. Brabletz T., Pfeuffer I., Schorr E., Siebelt F., Wirth T. and Serfling E. (1993) Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Molec. Cell. Biol 13, 1155-1162.
6. Bruijn M. H. L. de and Fey G. H. (1985) Human complement component C3: cDNA coding sequence and derived primary structure. Proc. natn. Acad. Sci. U.S.A. 82, 708-712.
7. Calabresi P. A., Hanham A., Carlino J., Olsen J., Maloni H., McFarland H. F. and Racke M. K. (1995) Report of an ongoing phase I trial of recombinant transforming growth factor-beta 2 (TGF-β2) in chronic progressive multiple sclerosis. Neurology 45, 417-418.
8. Chantry D., Turner M., Abney E. and Feldman M. (1989) Modulation of cytokine production by transforming growth factor-β1. J. Immun. 142, 4295-4300.
9. Danielson P. E., Forss-Petter S., Brow M. A., Calavette L., Douglass J., Milner J. and Sutcliffe J. G. (1988) A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7, 261-267.
10. Dasch J. R., Pace D. R., Waegell W., Inenaga D. and Ellingsworth L. (1989) Monoclonal antibodies recognize transforming growth factor-β. Bioactivity neutralization and transforming growth factor-β2 affinity purification. J. Immun. 142, 1536-1541.
11. De Benedetti F., Falk L. A., Ellingsworth L. R., Ruscetti F. W. and Faltynek C. R. (1990) Synergy between transforming growth factor-β and tumor necrosis-α in the induction of monocytic differentiation of human leukemic cell lines. Blood 75, 626-632.
12. Dubois C. M., Ruscetti F. W., Palaszynski E. W., Falk L. A., Oppenheim J. J. and Keller J. R. (1990) Transforming growth factor-β is a potent inhibitor of interleukin 1 (IL-1 receptor expression: proposed mechanism of inhibition of IL-1 action). J. Exp. Med. 172, 737-744.
13. Feinberg A. P. and Vogelstein B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analyt. Biochem. 132, 6-13.
14. Gamble J. R. and Vadas M. A. (1989) Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β1. Science 242, 97-99.
15. Gamble J. R. and Vadas M. A. (1991) Endothelial adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β1. J. Immun. 146, 1149-1154.
16. Groot R. P. de and Kruijer W. (1990) Transcriptional activation by TGF-β1 mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE). Biochem. Biophys. Res. Commun. 168, 1074-1081.
17. Hogansen A. K. M., Hestdal K., Hogansen K. and Abrahamsen T. G. (1995) Transforming growth factor-β modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytes. J. Leukoc. Biol. 57, 287-296.
18. Kerr L. D., Miller D. B. and Matrisian L. M. (1990) TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61, 267-278.
19. Kim S., Angel P., Lafyatis R., Hattori K., Kim K. Y., Sporn M., Karin M. and Roberts A. B. (1990) Autoinduction of transforming growth factor-β1 is mediated by the AP-1 complex. Molec. Cell. Biol. 10, 1492-1497.
20. Kulkarni A. B., Huh C.-G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M. and Karlsson S. (1993) Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. natn. Acad. Sci. U.S.A. 90, 770-774.
21. Lastres P., Almendro N., Bellon T., Lopez-Guerrero J. A., Eritja R. and Bernabeu C. (1994) Functional regulation of platelet/endothelial cell adhesion molecule-1 by TGF-β1 in promonocytic U937 cells. J. Immun. 153, 4206-4218.
22. Lin Y.-C. and Stavnezer J. (1992) Regulation of transcription of the germ-line Igα constant region gene by an ATF element and by novel transforming growth factor-β1 response elements. J. Immun. 149, 2914-2925.
23. McCartney-Francis N. L., Mizel D., Wong H., Wahl L. M. and Wahl S. M. (1990) TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors 4, 27-35.
24. McCartney-Francis N. L. and Wahl S. M. (1994) Transforming growth factor-β: a matter of life and death. J. Leukoc. Biol. 55, 401-409.
25. Massague J. A. (1990) The transforming growth factor-β family. Ann. Rev. Cell Biol. 6, 597-641.
26. Mauviel A., Chen Y. Q., Dong W., Evans C. H. and Uitto J. (1993) Transcriptional interactions of transforming growth factor-β with proinflammatory cytokines. Curr. Biol. 3, 822-831.
27. Morgan T. E., Laping N.20J., Rozousky I., Oda T., Hogan T. H., Finch C. E. and Pasinetti G. M. (1995) Clusterin expression by astrocytes is influenced by transforming growth factor-β1 and heterotypic cell interactions. J. Neuroimmun. 58, 101-110.
28. Pinson D. M., LeClaire R. D., Lorsbach R. B., Parmley M. J. and Russell S. W. (1992) Regulation by transforming growth factor-β1 of expression and function of the receptor for IFN-γ on mouse macrophages. J. Immun. 149, 2028-2034.
29. Reimold A. M., Kara C. J., Rooney J. W. and Glimcher L. H. (1993) Transforming growth factor β1 repression of the HLA-DRα gene is mediated by conserved proximal promoter elements. J. Immun. 151, 4173-4182.
30. Riccio A., Pedone P. V., Lund L. R., Olesen T., Olsen H. S. and Andreasen P. A. (1992) Transforming growth factor β1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear Factor I in the type 1 plasminogen activator inhibitor gene. Molec. Cell. Biol. 12, 1846-1855
31. Roberts A. B. and Sporn M. B. (1990) The transforming growth factor βs. In Peptide Growth Factors and their Receptors (Edited by Sporn M. B. and Roberts A. B.), p. 419. Springer, Heidelberg.
32. Rokita H. and Szuba K. (1991) Regulation of acute phase reaction by transforming growth factor β in cultured murine hepatocytes. Acta Biochim. Polonica 38, 241-249.
33. Rossi P., Karsenty G., Roberts A. B., Roche N. S., Sporn M. B. and Crombugghe B. de (1988) A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 52, 405-414.
34. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N. and Doetschman T. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
35. Smith P. D. and Kanof M. E. (1994) Immunologic studies in humans. In Current Protocols in Immunology (Edited by Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M. and Strober W.), Vol. 1, p. 7.1.1. John Wiley, Chichester.
36. Steinbach M. and Audran R. (1969) The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch. Biochem. Biophys. 134, 279-284.
37. Sundstrom C. and Nilsson K. (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17, 565-577.
38. Taylor A. W., Ku N. and Mortensen R. F. (1990) Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-β. J. Immun. 145, 2507-2513.
39. Testa U., Masciulli R., Tritarelli E., Pustorino R., Mariani G., Martucci R., Barberi T., Camagna A., Valtieri M. and Peschle C. (1993) Transforming growth factor-β potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. J. Immun. 150, 2418-2430.
40. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T. and Tada K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26, 171-176.
41. Turner M., Chantry D. and Feldmann M. (1990) Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 2, 211-216.
42. Vik D. P., Amiguet P., Moffat G. J., Fey M., Amiguet-Barras F., Wetsel R. A. and Tack B. F. (1991) Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence. Biochemistry 30, 1080-1085.
43. Wahl S. M., Costa G. L., Corcoran M., Wahl L. M. and Berger A. E. (1993) Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J. Immun. 150, 3553-3560.
44. Wahl S. M., Hunt D. A., Wakefield L., McCartney-Francis N. L., Wahl L. M., Roberts A. B. and Sporn M. B. (1987) Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc. natn. Acad. Sci. U.S.A. 84, 5788-5792.
45. Westerhausen D. R. Jr, Hopkins W. E. and Billadello J. J. (1991) Multiple transforming growth factor-β-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in HepG2 cells. J. Biol. Chem. 266, 1092-1100.
46. Wiseman D. M., Polverini P. J., Kamp D. W. and Leibovich S. J. (1988) Transforming growth factor-beta (TGF-β) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem. Biophys. Res. Commun. 157, 793-800.